There's new management in town, so investors are hoping there will be positive changes.
The biotech could be worth a lot more in 10 years.
These stocks all pay more than 3%, and they have been regularly increasing their payouts in recent years.
We'll know a little more about the biotech's prospects in a year and a half.
It's all about maintaining the right perspective.
These stocks pay above-average yields, and their dividend income could rise higher in the future.
This is what could happen next to Palo Alto Networks shares.
